212 participants
A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-28
- Start Date:
- 2018-10-31
- Completion:
- 2022-05-03
Conditions
- Pan Tumor
Interventions
- BIOLOGICAL